ArticleSurgical case reports2026
A Case of Recurrent Refractory Stomal Variceal Bleeding Associated with Oxaliplatin-Induced Portal Hypertension.
Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionStomal variceal bleeding is a rare but potentially life-threatening complication in patients with gastrointestinal stomas complicated by portal hypertension. Although oxaliplatin-based chemotherapy is widely used for colorectal cancer, it is known to cause sinusoidal obstruction syndrome (SOS), which may result in non-cirrhotic portal hypertension. However, stomal variceal bleeding secondary to oxaliplatin-induced portal hypertension has rarely been reported. CASE PRESENTATION: A 67-year-old man underwent curative surgery for rectal cancer, followed by 12 courses of oxaliplatin-based chemotherapy for pelvic recurrence. During chemotherapy, progressive anal pain led to the creation of a colostomy. After resumption of chemotherapy, recurrent and refractory stomal bleeding developed following an additional 5 courses. Despite conservative management, including local hemostatic measures and blood transfusions, the bleeding persisted. CT and laboratory examinations revealed splenomegaly, dilatation of the portal and mesenteric veins, and thrombocytopenia without evidence of liver cirrhosis. Based on these findings, portal hypertension caused by oxaliplatin-induced SOS was considered the most likely etiology of the stomal varices. Percutaneous transhepatic obliteration (PTO) was therefore performed and successfully achieved complete hemostasis without recurrence.
conclusionsClinicians should be aware that oxaliplatin-induced portal hypertension can cause stomal variceal bleeding even in the absence of liver cirrhosis. Careful long-term monitoring for portal hypertensive complications is warranted in patients receiving prolonged oxaliplatin-based chemotherapy. Percutaneous transhepatic variceal obliteration represents a safe and effective treatment option for refractory stomal variceal bleeding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.